↓ Skip to main content

Neoadjuvant isolated limb perfusion in newly diagnosed untreated patients with locally advanced soft tissue sarcomas of the extremities: the Gustave Roussy experience

Overview of attention for article published in Clinical and Translational Oncology, January 2019
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (72nd percentile)
  • Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

twitter
9 X users

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
22 Mendeley
Title
Neoadjuvant isolated limb perfusion in newly diagnosed untreated patients with locally advanced soft tissue sarcomas of the extremities: the Gustave Roussy experience
Published in
Clinical and Translational Oncology, January 2019
DOI 10.1007/s12094-019-02034-w
Pubmed ID
Authors

T. Assi, A. Cavalcanti, A. Le Cesne, M. Faron, J. F. Honart, A. Hadiji, O. Camuzard, T. Ibrahim, C. LePéchoux, O. Mir, S. Dumont, P. Terrier, J. Adam, C. Honoré

X Demographics

X Demographics

The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 22 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 22 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 4 18%
Other 3 14%
Student > Doctoral Student 3 14%
Student > Bachelor 2 9%
Student > Postgraduate 2 9%
Other 3 14%
Unknown 5 23%
Readers by discipline Count As %
Medicine and Dentistry 12 55%
Nursing and Health Professions 1 5%
Pharmacology, Toxicology and Pharmaceutical Science 1 5%
Unknown 8 36%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 January 2020.
All research outputs
#6,421,613
of 25,595,500 outputs
Outputs from Clinical and Translational Oncology
#288
of 1,469 outputs
Outputs of similar age
#123,370
of 448,420 outputs
Outputs of similar age from Clinical and Translational Oncology
#12
of 33 outputs
Altmetric has tracked 25,595,500 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 1,469 research outputs from this source. They receive a mean Attention Score of 4.1. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 448,420 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 33 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.